Chabiotech Co., Ltd

Clinical trials sponsored by Chabiotech Co., Ltd, explained in plain language.

Chabiotech Co., Ltd 085660 KOSDAQ

A South Korean biopharmaceutical company developing vaccines and therapeutics.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

Stem cell shot aims to restore ovarian function in small safety trial

Disease control Completed

This early-stage study tested whether a single injection of stem cells from donated umbilical cords is safe for women with premature ovarian insufficiency (early menopause). Only 6 women took part, and the main goal was to check for side effects, not to prove it works. Researcher…

Phase 1 • Sponsor: CHABiotech CO., Ltd • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

Chabiotech Co., Ltd

Stem cell shot aims to restore ovarian function in small safety trial